1 study found for:    11888076 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  A Phase II Study of Rituximab Combined With CHOP in T-Cell Angio-Immunoblastic Lymphoma
Condition: Untreated T-Cell Angioimmunoblastic Lymphoma
Intervention: Drug: Rituximab + CHOP regimen

Indicates status has not been verified in more than two years